Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= TXNIP ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: TXNIP * **<color #00a2e8>Official Name</color>**: thioredoxin interacting protein * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10628|10628]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/Q9H3M7|Q9H3M7]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=TXNIP&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TXNIP|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/606599|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: N/A * **<color #00a2e8>UniProt Summary</color>**: May act as an oxidative stress mediator by inhibiting thioredoxin activity or by limiting its bioavailability. Interacts with COPS5 and restores COPS5-induced suppression of CDKN1B stability, blocking the COPS5-mediated translocation of CDKN1B from the nucleus to the cytoplasm. Functions as a transcriptional repressor, possibly by acting as a bridge molecule between transcription factors and corepressor complexes, and over- expression will induce G0/G1 cell cycle arrest. Required for the maturation of natural killer cells. Acts as a suppressor of tumor cell growth. Inhibits the proteasomal degradation of DDIT4, and thereby contributes to the inhibition of the mammalian target of rapamycin complex 1 (mTORC1). {ECO:0000269|PubMed:12821938, ECO:0000269|PubMed:17603038, ECO:0000269|PubMed:18541147, ECO:0000269|PubMed:21460850}. <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |Arrestin C| |Arrestin N| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |cellular response to tumor cell| |response to tumor cell| |negative regulation of cell division| |enzyme inhibitor activity| |platelet-derived growth factor receptor signaling pathway| |response to progesterone| |mitochondrial intermembrane space| |protein import into nucleus| |import into nucleus| |response to hydrogen peroxide| |response to estradiol| |response to glucose| |protein import| |response to hexose| |response to monosaccharide| |response to calcium ion| |protein localization to nucleus| |regulation of cell division| |response to carbohydrate| |response to ketone| |response to reactive oxygen species| |response to mechanical stimulus| |cellular response to biotic stimulus| |nucleocytoplasmic transport| |nuclear transport| |keratinocyte differentiation| |ubiquitin protein ligase binding| |response to antibiotic| |epidermal cell differentiation| |response to steroid hormone| |response to metal ion| |skin development| |response to oxidative stress| |epidermis development| |establishment of protein localization to organelle| |response to toxic substance| |transmembrane receptor protein tyrosine kinase signaling pathway| |response to inorganic substance| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |epithelial cell differentiation| |positive regulation of cell death| |enzyme linked receptor protein signaling pathway| |protein localization to organelle| |negative regulation of catalytic activity| |response to lipid| |negative regulation of transcription by RNA polymerase II| |response to hormone| |response to organic cyclic compound| |intracellular protein transport| |response to drug| |epithelium development| |negative regulation of molecular function| |response to abiotic stimulus| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |response to biotic stimulus| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |protein transport| |negative regulation of cellular biosynthetic process| |intracellular transport| |peptide transport| |regulation of apoptotic process| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |regulation of programmed cell death| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |regulation of cell population proliferation| |regulation of cell death| |negative regulation of gene expression| |tissue development| |establishment of localization in cell| |nitrogen compound transport| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='primary' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp515|PU-H71 1μM R08 exp515]]|-2.9| |[[:results:exp539|42°C R08 exp539]]|-2.03| |[[:results:exp116|AICAR 240μM R03 exp116]]|-1.97| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.87| |[[:results:exp527|Tanespimycin 14μM R08 exp527]]|-1.84| |[[:results:exp469|CFI-400945 25μM R08 exp469]]|-1.71| |[[:results:exp224|CB-839 10μM R05 exp224]]|1.71| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|1.72| |[[:results:exp399|Salubrinal 20μM R07 exp399]]|1.72| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|1.73| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|1.78| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.84| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.89| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.09| |[[:results:exp283|Glyphosate 1000μM R06 exp283]]|2.15| |[[:results:exp346|CoCl2 18μM R07 exp346]]|2.22| |[[:results:exp359|FK-506 30μM R07 exp359]]|2.29| |[[:results:exp492|iCRT14 30μM R08 exp492]]|2.33| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|2.38| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.47| |[[:results:exp85|UM0129480 7μM R02 exp85]]|2.89| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|4.16| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|4.37| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|4.53| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|8.44| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> ^Gene^Correlation^ |[[:human genes:m:mlx|MLX]]|0.736| |[[:human genes:m:mlxip|MLXIP]]|0.621| |[[:human genes:m:msi2|MSI2]]|0.404| </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 13986 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 6.02 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='TXNIP Expression in NALM6 Cells: 6.02'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2026/01/07 22:37by 127.0.0.1